David H. Spencer, MD, PhD

Medical Director, McDonnell Genome Institute Clinical Sequencing Lab

Washington University in St. Louis (WU)

My lab studies the genomics and epigenomics of AML, with an emphasis on how AML mutations alter the epigenome and gene expression. I am also interested in developing genomic methods for diagnosis and disease monitoring in AML patients.